Latvia - Antihypertensive Medicine Use
Since 2014, Latvia Antihypertensive Medicine Use increased 7.7% year on year. At 13.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 5 among other countries in Antihypertensive Medicine Use. Latvia is overtaken by Slovenia, which was number 4 with 14.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by United Kingdom with 13.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 34.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +4.2% versus 2018. Canada witnessed the best average annual growth at +10.3% per year, while Slovakia witnessed the worst performance at -9.8% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 13.50 |
2018 | 12.00 |
2017 | 11.40 |
2016 | 10.40 |
2015 | 9.80 |
How does Latvia rank in Antihypertensive Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
35 | 2019 | +4.2 % | +4.2 % | View data | |
2 |
#2
Lithuania
|
24 | 2019 | +4.7 % | -3.6 % | View data | |
4 |
#4
Slovenia
|
15 | 2019 | +0.7 % | +0.0 % | View data | |
5 |
#5
Latvia
|
14 | 2019 | +12.5 % | +7.7 % | View data | |
6 |
#6
United Kingdom
|
13 | 2019 | -0.7 % | -0.7 % | View data |